Castle Biosciences, Inc. (NASDAQ: CSTL)
$25.0500
-0.4100 ( -4.17% ) 173.6K
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Market Data
Open
$25.0500
Previous close
$25.4600
Volume
173.6K
Market cap
$690.94M
Day range
$24.6690 - $26.6590
52 week range
$16.9650 - $35.8400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jan 15, 2025 |
| 4 | Insider transactions | 1 | Jan 08, 2025 |
| 4 | Insider transactions | 1 | Jan 08, 2025 |
| 4 | Insider transactions | 1 | Dec 19, 2024 |
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 4 | Insider transactions | 1 | Dec 11, 2024 |
| 4 | Insider transactions | 1 | Dec 11, 2024 |
| 4 | Insider transactions | 1 | Dec 11, 2024 |
| 4 | Insider transactions | 1 | Dec 11, 2024 |
| 4 | Insider transactions | 1 | Dec 09, 2024 |